Riskpilot← Back to searchSign inGet full accessHMS INNOVASJON AS
ASActiveOrg 898062422Daas Gate 15B, 0259 OsloOther human health activities n.e.c. · NACE 8699Est. 20122 employees
Revenue 2024
NOK 457K
+145% vs 2023
EBITDA margin
73.9%
+451% vs 2023
Equity ratio
82.7%
Financial strength
Net profit 2024
NOK 313K
+411% vs 2023
| Revenue | NOK 457K | +145% |
| EBITDA | NOK 337K | +451% |
| Net profit | NOK 313K | +411% |
| Total assets | NOK 140K | +212% |
| Equity | NOK 116K | +159% |
| Employees | 2 | — |
Legal name
HMS INNOVASJON AS
Org number
898062422
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
27. juni 2012
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Forebyggende helsearbeid samt investering i andre selskaper og tilhørende virksomhet. Kjøp og salg av aksjer, verdipapirer og formuesverdier av enhver art.
Address
Daas Gate 15B, 0259 Oslo
Phone
+4748293884
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 393 | 330 | 201 | 186 | 457 |
| Staff expenses | −45 | −137 | −190 | −0 | −0 |
| EBITDA | 201 | 137 | −73 | 61 | 337 |
| Depreciation & amort. | −54 | −0 | −0 | −0 | −0 |
| EBIT | 147 | 137 | −73 | 61 | 337 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 147 | 137 | −73 | 61 | 338 |
| Tax | −0 | −0 | −0 | −0 | 24 |
| Net profit | 147 | 137 | −73 | 61 | 313 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 107 | 45 | 8 | 45 | 140 |
| Equity | −322 | −185 | −259 | −197 | 116 |
| Long-term debt | 365 | 150 | 150 | 158 | 18 |
| Short-term debt | 64 | 80 | 116 | 84 | 7 |
| Total debt | 429 | 230 | 266 | 242 | 24 |
EBITDA margin
73.9%
This company
15.8%
Market median
+368% vs market
20202024
Equity ratio
82.7%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
270.3%
This company
18.4%
Market median
+1369% vs market
20202024
Net profit margin
68.6%
This company
8.1%
Market median
+747% vs market
20202024
Asset turnover
3.26×
This company
1.12×
Market median
+191% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CG Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HMS INNOVASJON AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christina Gunvor Lundeberg | Chief Executive Officer | 0 companies |
| Gunnar Moe Areklett | Chairman | 0 companies |